Alessandro Gronchi Selected Research

Solitary Fibrous Tumors

1/2020	Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet.
8/2015	Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation.
6/2014	Emerging therapies for adult soft tissue sarcoma.
9/2013	Adjuvant therapy for high-risk soft tissue sarcoma in the adult.
5/2010	Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Gronchi Research Topics

Disease

112	Neoplasms (Cancer) 10/2023 - 08/2003
105	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 08/2004
21	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023 - 07/2004
20	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2004
17	Liposarcoma 07/2023 - 07/2007
15	Myxoid Liposarcoma 01/2024 - 07/2007
12	Leiomyosarcoma 01/2023 - 12/2010
9	Aggressive Fibromatosis (Desmoid) 01/2021 - 09/2007
7	Chordoma 10/2018 - 11/2004
6	Dermatofibrosarcoma 01/2017 - 10/2005
5	Retroperitoneal liposarcoma 07/2023 - 12/2010
5	Pain (Aches) 01/2023 - 03/2012
5	Fibroma (Fibromatosis) 01/2021 - 12/2015
5	Extraskeletal Myxoid Chondrosarcoma 12/2020 - 10/2012
5	Solitary Fibrous Tumors 01/2020 - 05/2010
5	Synovial Sarcoma (Synovioma) 06/2017 - 02/2004
4	Hemangiosarcoma (Angiosarcoma) 05/2023 - 06/2014
4	Hyperthermia 07/2021 - 09/2002
4	Neurofibrosarcoma (MPNST) 01/2020 - 09/2003
3	Chondrosarcoma 01/2024 - 01/2019
3	Inflammation (Inflammations) 01/2023 - 09/2011
3	Disease Progression 01/2021 - 09/2013
3	Alveolar Soft Part Sarcoma 06/2014 - 02/2009
2	Rectal Neoplasms (Rectal Cancer) 05/2024 - 12/2020
2	Thymoma (Thymic Carcinoma) 10/2023 - 12/2009
2	Necrosis 01/2023 - 04/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 07/2017
2	Perivascular Epithelioid Cell Neoplasms 10/2020 - 01/2019
2	Neutropenia 01/2020 - 01/2017
2	Infections 03/2019 - 01/2019
2	Melanoma (Melanoma, Malignant) 03/2019 - 02/2012
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2017 - 12/2009
2	Fibrosarcoma 06/2014 - 10/2011
2	Clear Cell Sarcoma 09/2013 - 02/2012
2	Margins of Excision 02/2013 - 03/2010
2	Rare Diseases (Rare Disease) 03/2012 - 09/2002
2	Carcinoma (Carcinomatosis) 12/2010 - 09/2002
1	Desmoplastic Small Round Cell Tumor 01/2023

Drug/Important Bio-Agent (IBA)

33	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 07/2004
19	TrabectedinIBA 01/2023 - 07/2007
17	Ifosfamide FDA LinkGeneric 01/2024 - 01/2014
11	AnthracyclinesIBA 01/2024 - 12/2013
10	Proteins (Proteins, Gene)FDA Link 06/2020 - 07/2007
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 05/2004
8	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2015 - 11/2004
8	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2012 - 02/2004
7	Gemcitabine FDA Link 01/2020 - 06/2014
6	Tyrosine Kinase InhibitorsIBA 08/2019 - 07/2004
5	pazopanib FDA Link 01/2023 - 06/2014
5	Sunitinib (Sutent)FDA Link 06/2018 - 02/2009
5	Phosphotransferases (Kinase)IBA 01/2015 - 02/2004
4	CateninsIBA 01/2021 - 10/2013
4	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 06/2014
4	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 11/2015 - 09/2007
4	Platelet-Derived Growth FactorIBA 03/2012 - 10/2005
4	LigandsIBA 08/2010 - 02/2004
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2017
3	Dihydrotachysterol (AT 10)IBA 01/2022 - 10/2005
3	MTOR InhibitorsIBA 10/2020 - 08/2010
3	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 01/2017
3	Epirubicin (Ellence)FDA LinkGeneric 06/2017 - 11/2015
3	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2012 - 09/2006
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 03/2010
2	eribulin FDA Link 01/2023 - 08/2019
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2023 - 03/2017
2	nilotinib FDA Link 12/2021 - 05/2013
2	multidrug resistance-associated protein 1IBA 12/2021 - 01/2014
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 03/2017
2	Vinca AlkaloidsIBA 01/2021 - 03/2017
2	Hormones (Hormone)IBA 11/2020 - 01/2019
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2020 - 01/2019
2	Sirolimus (Rapamycin)FDA Link 10/2020 - 01/2016
2	Pioglitazone (Actos)FDA Link 03/2020 - 12/2019
2	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2017
2	TOR Serine-Threonine KinasesIBA 10/2018 - 12/2009
2	Formaldehyde (Formol)FDA Link 01/2016 - 08/2010
2	beta CateninIBA 01/2016 - 09/2007
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2013 - 03/2012
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012 - 02/2004
2	Complement System Proteins (Complement)IBA 05/2009 - 07/2007
1	hypoiodous acid (HOI)IBA 07/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Melphalan (Alkeran)FDA LinkGeneric 01/2023

Therapy/Procedure

55	Drug Therapy (Chemotherapy) 05/2024 - 08/2004
40	Radiotherapy 04/2024 - 06/2007
38	Therapeutics 12/2022 - 08/2003
26	Neoadjuvant Therapy 01/2024 - 09/2013
7	Adjuvant Chemotherapy 01/2022 - 08/2004
4	Operative Surgical Procedures 10/2023 - 01/2018
4	Surgical Amputation (Amputations) 01/2023 - 12/2007
4	Hyperthermic Intraperitoneal Chemotherapy 01/2023 - 12/2010
4	Pancreatectomy 03/2022 - 03/2011
3	Precision Medicine 01/2023 - 08/2017
3	Cytoreduction Surgical Procedures 04/2021 - 09/2002
3	Catheters 03/2019 - 01/2016
3	Molecular Targeted Therapy 12/2010 - 11/2004
2	Immunotherapy 01/2022 - 01/2017
2	Morcellation 11/2020 - 05/2016
1	Palliative Care (Palliative Therapy) 05/2024
1	Heavy Ion Radiotherapy 01/2024